693 related articles for article (PubMed ID: 28087531)
1. Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients.
Tian N; Faller L; Leffler DA; Kelly CP; Hansen J; Bosch JA; Wei G; Paster BJ; Schuppan D; Helmerhorst EJ
Appl Environ Microbiol; 2017 Mar; 83(6):. PubMed ID: 28087531
[TBL] [Abstract][Full Text] [Related]
2. The human digestive tract has proteases capable of gluten hydrolysis.
Gutiérrez S; Pérez-Andrés J; Martínez-Blanco H; Ferrero MA; Vaquero L; Vivas S; Casqueiro J; Rodríguez-Aparicio LB
Mol Metab; 2017 Jul; 6(7):693-702. PubMed ID: 28702325
[TBL] [Abstract][Full Text] [Related]
3. Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract.
Zamakhchari M; Wei G; Dewhirst F; Lee J; Schuppan D; Oppenheim FG; Helmerhorst EJ
PLoS One; 2011; 6(9):e24455. PubMed ID: 21957450
[TBL] [Abstract][Full Text] [Related]
4. Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity.
Caminero A; Galipeau HJ; McCarville JL; Johnston CW; Bernier SP; Russell AK; Jury J; Herran AR; Casqueiro J; Tye-Din JA; Surette MG; Magarvey NA; Schuppan D; Verdu EF
Gastroenterology; 2016 Oct; 151(4):670-83. PubMed ID: 27373514
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity.
Helmerhorst EJ; Zamakhchari M; Schuppan D; Oppenheim FG
PLoS One; 2010 Oct; 5(10):e13264. PubMed ID: 20948997
[TBL] [Abstract][Full Text] [Related]
6. Selected Probiotic Lactobacilli Have the Capacity To Hydrolyze Gluten Peptides during Simulated Gastrointestinal Digestion.
Francavilla R; De Angelis M; Rizzello CG; Cavallo N; Dal Bello F; Gobbetti M
Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500039
[TBL] [Abstract][Full Text] [Related]
7. The cultivable human oral gluten-degrading microbiome and its potential implications in coeliac disease and gluten sensitivity.
Fernandez-Feo M; Wei G; Blumenkranz G; Dewhirst FE; Schuppan D; Oppenheim FG; Helmerhorst EJ
Clin Microbiol Infect; 2013 Sep; 19(9):E386-94. PubMed ID: 23714165
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten.
Duar RM; Clark KJ; Patil PB; Hernández C; Brüning S; Burkey TE; Madayiputhiya N; Taylor SL; Walter J
J Appl Microbiol; 2015 Feb; 118(2):515-27. PubMed ID: 25376327
[TBL] [Abstract][Full Text] [Related]
9. Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease.
Tian N; Leffler DA; Kelly CP; Hansen J; Marietta EV; Murray JA; Schuppan D; Helmerhorst EJ
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(11):G910-7. PubMed ID: 26505973
[TBL] [Abstract][Full Text] [Related]
10. A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides.
Moreno Amador ML; Arévalo-Rodríguez M; Durán EM; Martínez Reyes JC; Sousa Martín C
PLoS One; 2019; 14(6):e0218346. PubMed ID: 31246975
[TBL] [Abstract][Full Text] [Related]
11. Gluten-degrading bacteria are present in the human small intestine of healthy volunteers and celiac patients.
Herrán AR; Pérez-Andrés J; Caminero A; Nistal E; Vivas S; Ruiz de Morales JM; Casqueiro J
Res Microbiol; 2017 Sep; 168(7):673-684. PubMed ID: 28526528
[TBL] [Abstract][Full Text] [Related]
12. Identification of Pseudolysin (lasB) as an Aciduric Gluten-Degrading Enzyme with High Therapeutic Potential for Celiac Disease.
Wei G; Tian N; Valery AC; Zhong Y; Schuppan D; Helmerhorst EJ
Am J Gastroenterol; 2015 Jun; 110(6):899-908. PubMed ID: 25895519
[TBL] [Abstract][Full Text] [Related]
13. Differences in gluten metabolism among healthy volunteers, coeliac disease patients and first-degree relatives.
Caminero A; Nistal E; Herrán AR; Pérez-Andrés J; Ferrero MA; Vaquero Ayala L; Vivas S; Ruiz de Morales JM; Albillos SM; Casqueiro FJ
Br J Nutr; 2015 Oct; 114(8):1157-67. PubMed ID: 26428276
[TBL] [Abstract][Full Text] [Related]
14. Identification of food-grade subtilisins as gluten-degrading enzymes to treat celiac disease.
Wei G; Tian N; Siezen R; Schuppan D; Helmerhorst EJ
Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G571-80. PubMed ID: 27469368
[TBL] [Abstract][Full Text] [Related]
15. Salivary and fecal microbiota and metabolome of celiac children under gluten-free diet.
De Angelis M; Vannini L; Di Cagno R; Cavallo N; Minervini F; Francavilla R; Ercolini D; Gobbetti M
Int J Food Microbiol; 2016 Dec; 239():125-132. PubMed ID: 27452636
[TBL] [Abstract][Full Text] [Related]
16. Dietary Gluten-Induced Gut Dysbiosis Is Accompanied by Selective Upregulation of microRNAs with Intestinal Tight Junction and Bacteria-Binding Motifs in Rhesus Macaque Model of Celiac Disease.
Mohan M; Chow CT; Ryan CN; Chan LS; Dufour J; Aye PP; Blanchard J; Moehs CP; Sestak K
Nutrients; 2016 Oct; 8(11):. PubMed ID: 27801835
[TBL] [Abstract][Full Text] [Related]
17. Human small-intestinal gluten-degrading bacteria and its potential implication in celiac disease.
Dewala S; Bodkhe R; Nimonkar Y; Prakash OM; Ahuja V; Makharia GK; Shouche YS
J Biosci; 2023; 48():. PubMed ID: 37309172
[TBL] [Abstract][Full Text] [Related]
18. Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease.
Caminero A; Herrán AR; Nistal E; Pérez-Andrés J; Vaquero L; Vivas S; Ruiz de Morales JM; Albillos SM; Casqueiro J
FEMS Microbiol Ecol; 2014 May; 88(2):309-19. PubMed ID: 24499426
[TBL] [Abstract][Full Text] [Related]
19. E40, a novel microbial protease efficiently detoxifying gluten proteins, for the dietary management of gluten intolerance.
Cavaletti L; Taravella A; Carrano L; Carenzi G; Sigurtà A; Solinas N; Caro S; Stasio LD; Picascia S; Laezza M; Troncone R; Gianfrani C; Mamone G
Sci Rep; 2019 Sep; 9(1):13147. PubMed ID: 31511534
[TBL] [Abstract][Full Text] [Related]
20. Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants.
Sellitto M; Bai G; Serena G; Fricke WF; Sturgeon C; Gajer P; White JR; Koenig SS; Sakamoto J; Boothe D; Gicquelais R; Kryszak D; Puppa E; Catassi C; Ravel J; Fasano A
PLoS One; 2012; 7(3):e33387. PubMed ID: 22432018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
